Retatrutide and Tirzepatide: Retatrutide and Tirzepatide are promising GLP-1 analogues currently under investigation in clinical trials for obesity treatment
PlexusDx serves all 50 states with no insurance required and HSA/FSA eligibility, making it feasible to stay on a maintenance dose long-term if you determine that's the right choice for your health goals
Update on genistein and thyroid: an overall message of safety
GLP-1 receptor agonist use was also associated with consistent reductions across both 1-year and 2-year follow-up periods in cellulitis, sepsis, acute kidney injury, dialysis initiation and suicidal ideation or attempts, the authors wrote
But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea
Be sure to tell your healthcare provider about all medications you are taking